Skip to main content
. 2011 Nov 4;4:44. doi: 10.1186/1756-8722-4-44

Table 1.

Glycoprotein IIb/IIIa antagonists

Agents Mechanism of action Administration Main side effects State
Abciximab inhibit GPIIb/IIIa receptor and GP αIIb/β3 receptor IV allergy, bleeding,
thrombocytopenia		 Approved
Eptifibatide inhibit GPIIb/IIIa receptor IV bleeding,
thrombocytopenia		 Approved
Tirofiban inhibit GP IIb/IIIa receptor IV bleeding,
thrombocytopenia		 approved

Abbreviations: GP: glycoprotein; IV: intravenous.